QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saito, K. Articles by Fujita, S. Search for Related Content PubMed PubMed Citation Articles by Saito, K. Articles by Fujita, S.

STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS

Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan

Knowledge of strain differences in drug metabolism is important for the selection of animals for pharmacokinetic, pharmacodynamic, and toxicological studies. Hepatic microsomes from Sprague-Dawley (SD) and Brown Norway (BN) rats had 300-fold higher diazepam p-hydroxylation activity than Dark Agouti (DA) and Wistar (W) rats at a low diazepam concentration (3 µM). Kinetic studies indicated that diazepam p-hydroxylation in SD and BN rats proceeded with lower K_m and higher V_max values than it did in DA and W rats. However, the expression levels of cytochrome P450 CYP2D1, the reported enzyme for diazepam p-hydroxylation, did not cosegregate with the activity. These results suggest the presence of a new high-affinity diazepam p-hydroxylation enzyme other than CYP2D1 in SD and BN rats. DA rats showed 3- and 2-fold higher diazepam 3-hydroxylation and N-desmethylation activities, respectively, than the other rat strains. In agreement with this, DA rat liver microsomes had a higher expression of CYP3A2, which is responsible for diazepam 3-hydroxylation and partly responsible for N-desmethylation. Values of CL_int (V_max/K_m) indicated that p-hydroxy-diazepam is the major metabolite in SD and BN rats, whereas 3-hydroxy-diazepam is the major metabolite in DA and W rats. The sum of the CL_int in each strain was in the order of DA > SD = BN >> W. Strain differences in the pharmacodynamics of diazepam between SD and DA rats may be due to these differences in diazepam metabolism. We found that both the rate of elimination of diazepam and the major metabolic pathways in diazepam metabolism differed among the different rat strains due to polymorphic expression of the two enzymes involved in diazepam metabolism.

This article has been cited by other articles:

				N. Sakai, K. Saito, K. Q. Sakamoto, M. Ishizuka, and S. Fujita Genetic Basis of Inter- and Intrastrain Differences in Diazepam p-Hydroxylation in Rats Drug Metab. Dispos., February 1, 2009; 37(2): 268 - 271. [Abstract] [Full Text] [PDF]

				M. Giantin, M. Carletti, F. Capolongo, S. Pegolo, R. M. Lopparelli, F. Gusson, C. Nebbia, M. Cantiello, P. Martin, T. Pineau, et al. Effect of Breed upon Cytochromes P450 and Phase II Enzyme Expression in Cattle Liver Drug Metab. Dispos., May 1, 2008; 36(5): 885 - 893. [Abstract] [Full Text] [PDF]

				T. Ito, M. Takahashi, K. Sudo, and Y. Sugiyama Marked Strain Differences in the Pharmacokinetics of an {alpha}4beta1 Integrin Antagonist, 4-[1-[3-Chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]-methoxybenzoic Acid (D01-4582), in Sprague-Dawley Rats Are Associated with Albumin Genetic Polymorphism J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 124 - 132. [Abstract] [Full Text] [PDF]

				N. Sakai, K. Saito, H.-S. Kim, A. Kazusaka, M. Ishizuka, Y. Funae, and S. Fujita IMPORTANCE OF CYP2D3 IN POLYMORPHISM OF DIAZEPAM P-HYDROXYLATION IN RATS Drug Metab. Dispos., November 1, 2005; 33(11): 1657 - 1660. [Abstract] [Full Text] [PDF]